CTCBIO Inc Cash Flow-to-Debt Ratio
CTCBIO Inc cash flow-to-debt ratio. CTCBIO Inc (060590) has a Cash Flow-to-Debt Ratio of 0.07x as of September 2025, meaning its operating cash flow of ₩5.64 Billion could theoretically repay 0% of its total liabilities (₩77.43 Billion) in one year. Check CTCBIO Inc (060590) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of CTCBIO Inc (2013–2024)
Cash flow-to-debt ratio of CTCBIO Inc from 2013 to 2024. Historical debt coverage capacity for CTCBIO Inc across 12 annual periods. Check 060590 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
CTCBIO Inc Cash Flow-to-Debt Ratio by Year (2013–2024)
CTCBIO Inc cash flow-to-debt ratio by year from 2013 to 2024. Year-by-year debt coverage analysis for CTCBIO Inc. For the full cash flow conversion analysis, see CTCBIO Inc (060590) cash conversion ratio.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.05x | ₩4.50 Billion | ₩84.07 Billion | ▼ -41.1% |
| 2023 | 0.09x | ₩8.22 Billion | ₩90.42 Billion | ▼ -54.2% |
| 2022 | 0.20x | ₩18.22 Billion | ₩91.94 Billion | ▲ +155.4% |
| 2021 | 0.08x | ₩6.46 Billion | ₩83.21 Billion | ▲ +1434.3% |
| 2020 | 0.01x | ₩510.09 Million | ₩100.86 Billion | ▼ -66.3% |
| 2019 | 0.01x | ₩1.68 Billion | ₩111.76 Billion | ▲ +163.5% |
| 2018 | -0.02x | ₩-2.47 Billion | ₩104.82 Billion | ▼ -1041.3% |
| 2017 | 0.00x | ₩295.30 Million | ₩117.82 Billion | ▼ -96.4% |
| 2016 | 0.07x | ₩6.86 Billion | ₩97.78 Billion | ▲ +361.4% |
| 2015 | 0.02x | ₩1.44 Billion | ₩94.47 Billion | ▲ +435.3% |
| 2014 | 0.00x | ₩-347.74 Million | ₩76.63 Billion | ▼ -109.6% |
| 2013 | 0.05x | ₩2.74 Billion | ₩58.25 Billion | — |